A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.

A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.

Type 2 innate lymphoid cells (ILC2s, nuocytes, NHC) require RORA and GATA3 for their development. We show that human ILC2s express skin homing receptors and infiltrate the skin after allergen challenge, where they produce the type 2 cytokines IL-5 and IL-13. Skin-derived ILC2s express the IL-33 rece...

Bibliografiset tiedot
Päätekijät:	Salimi, M, Barlow, J, Saunders, S, Xue, L, Gutowska-Owsiak, D, Wang, X, Huang, L, Johnson, D, Scanlon, S, McKenzie, A, Fallon, P, Ogg, G
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	Rockefeller University Press. 2013

Samankaltaisia teoksia

The role of type 2 innate lymphoid cells in the pathogenesis of atopic dermatitis
Tekijä: Salimi, M, et al.
Julkaistu: (2014)

Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis
Tekijä: Chen, Y, et al.
Julkaistu: (2019)

IL-17A and IL-22 cause down-regulation of filaggrin - implications for the pathogenesis of atopic eczema
Tekijä: Gutowska-Owsiak, D, et al.
Julkaistu: (2010)

Interleukin-22-mediated downregulation of filaggrin expression in keratinocytes is an important mechanism in pathogenesis of atopic dermatitis
Tekijä: Gutowska-Owsiak, D, et al.
Julkaistu: (2010)

Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity.
Tekijä: Saunders, S, et al.
Julkaistu: (2015)

IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
Tekijä: Hardman, CS, et al.
Julkaistu: (2021)

Association between IL-25, IL-33 and atopic dermatitis: A systematic review and meta-analysis
Tekijä: Boyang Zhou, et al.
Julkaistu: (2023-06-01)

Association between polymorphisms of <i>IL33</i> and <i>IL37</i> and atopic dermatitis
Tekijä: O. A. Svitich, et al.
Julkaistu: (2024-11-01)

IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells
Tekijä: Ana Camelo, et al.
Julkaistu: (2017-04-01)

IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis
Tekijä: Jessica E. Miller, et al.
Julkaistu: (2021-12-01)

Innate lymphoid cells: a new key player in atopic dermatitis
Tekijä: Haiping Jia, et al.
Julkaistu: (2023-10-01)

IL-22 in Atopic Dermatitis
Tekijä: Julia Laska, et al.
Julkaistu: (2024-08-01)

Identification and functional analysis of type 2 innate lymphoid cells in the skin and in lesional skin biopsies of patients with atopic dermatitis
Tekijä: Salimi, M
Julkaistu: (2014)

IL-33-induced keratoconjunctivitis is mediated by group 2 innate lymphoid cells in mice
Tekijä: Yuka Hosotani, et al.
Julkaistu: (2023-04-01)

Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis
Tekijä: Eric Jou, et al.
Julkaistu: (2022-10-01)

IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion.
Tekijä: Gutowska-Owsiak, D, et al.
Julkaistu: (2012)

IL-17 influences expression of genes associated with barrier function in keratinocytes
Tekijä: Gutowska-Owsiak, D, et al.
Julkaistu: (2011)

Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis.
Tekijä: Chun-Kwok Wong, et al.
Julkaistu: (2012-01-01)

IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
Tekijä: Alyse L. Frisbee, et al.
Julkaistu: (2019-06-01)

IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to Toxoplasma gondii
Tekijä: Joseph T Clark, et al.
Julkaistu: (2021-04-01)

MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion.
Tekijä: Oliphant, C, et al.
Julkaistu: (2016)

Microbiota and IL-33/31 Axis Linkage: Implications and Therapeutic Perspectives in Atopic Dermatitis and Psoriasis
Tekijä: Laura Bonzano, et al.
Julkaistu: (2023-07-01)

Evaluation of innate lymphoid cells and their subsets in atopic dermatitis patients with and without dupilumab therapy
Tekijä: Jarmila Čelakovská, et al.
Julkaistu: (2024-12-01)

Dupilumab Effects on Innate Lymphoid Cell and Helper T Cell Populations in Patients with Atopic Dermatitis
Tekijä: Yasutomo Imai, et al.
Julkaistu: (2021-03-01)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
Tekijä: Ogg, G, et al.
Julkaistu: (2015)

Interleukin-17 and interleukin-22 contribute to alterations in epidermal function via multiple pathways - role in atopic eczema
Tekijä: Gutowska-Owsiak, D, et al.
Julkaistu: (2011)

Pathogenetic role of IL-4 and IL-13 in atopic dermatitis: The inhibitory pathways
Tekijä: D. Sh. Macharadze
Julkaistu: (2025-03-01)

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells
Tekijä: Hardman, C, et al.
Julkaistu: (2017)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
Tekijä: Salimi, M, et al.
Julkaistu: (2015)

Potential Role of IL-37 in Atopic Dermatitis
Tekijä: Alicja Mesjasz, et al.
Julkaistu: (2023-12-01)

Targeting IL-4 for the Treatment of Atopic Dermatitis
Tekijä: Chiricozzi A, et al.
Julkaistu: (2020-09-01)

Interleukin-17 mediates adhesion impairment in human keratinocytes - potential involvement in barrier dysfunction during atopic skin inflammation
Tekijä: Gutowska-Owsiak, D, et al.
Julkaistu: (2012)

IL-33/13 Axis and IL-4/31 Axis Play Distinct Roles in Inflammatory Process and Itch in Psoriasis and Atopic Dermatitis
Tekijä: Bodoor K, et al.
Julkaistu: (2020-06-01)

P41 IL-33-MEDIATED EXPANSION OF TYPE 2 INNATE LYMPHOID CELLS AMELIORATES PROGRESSIVE GLOMERULOSCLEROSIS
Tekijä: M. Becker, et al.
Julkaistu: (2016-11-01)

The histamine-synthesizing enzyme histidine decarboxylase is upregulated by keratinocytes in atopic skin.
Tekijä: Gutowska-Owsiak, D, et al.
Julkaistu: (2014)

Expression of histamine-synthesizing enzyme, histidine decarboxylase, by keratinocytes and its regulation by cytokines and factors relevant to atopic skin disease
Tekijä: Gutowska-Owsiak, D, et al.
Julkaistu: (2013)

Selective IL-13 inhibitors for the treatment of atopic dermatitis
Tekijä: Francisca Gonçalves, et al.
Julkaistu: (2021-03-01)

Severe atopic dermatitis is associated with a reduced frequency of IL-10 producing allergen-specific CD4+ T cells.
Tekijä: Seneviratne, S, et al.
Julkaistu: (2006)

STING activation in alveolar macrophages and group 2 innate lymphoid cells suppresses IL-33–driven type 2 immunopathology
Tekijä: Li She, et al.
Julkaistu: (2021-02-01)

Serum Levels of Il-8, Tnf-α And Il-6 in Children with Atopic Dermatitis
Tekijä: Perihan Öztürk, et al.
Julkaistu: (2012-08-01)